Dalvance
Payments companies reported to CMS as associated with Dalvance. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Dalvance, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Dalvance
These are the largest totals companies reported as associated with Dalvance. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Frank Lovecchio | Phoenix, AZ | Internal Medicine | $324,280.36 |
| William Pace | Southampton, PA | Infectious Disease | $221,386.95 |
| Christian Sandrock | Sacramento, CA | Internal Medicine | $122,788.02 |
| Javeed Siddiqui | Roseville, CA | Infectious Disease | $82,504.11 |
| George Sakoulas | San Diego, CA | Infectious Disease | $62,877.67 |
| Mark Pierce | Cookeville, TN | Infectious Disease | $62,167.51 |
| David Mai | Miami Lakes, FL | Foot & Ankle Surgery | $56,289.64 |
| Leroy Vaughan | Richmond, VA | Internal Medicine | $54,187.32 |
| Juan Diaz | Altamonte Springs, FL | Infectious Disease | $54,036.61 |
| Harry Kopolovich | Bronx, NY | Emergency Medicine | $50,453.77 |
Prescribed Dalvance?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.